Syngene International Limited (SYNGENE) - Total Liabilities
Based on the latest financial reports, Syngene International Limited (SYNGENE) has total liabilities worth Rs18.07 Billion INR (≈ $195.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Syngene International Limited - Total Liabilities Trend (2010–2025)
This chart illustrates how Syngene International Limited's total liabilities have evolved over time, based on quarterly financial data. See SYNGENE current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Syngene International Limited Competitors by Total Liabilities
The table below lists competitors of Syngene International Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Borusan Mannesmann Boru Sanayi ve Ticaret AS
IS:BRSAN
|
Turkey | TL36.82 Billion |
|
Nyocor Co Ltd
SHG:600821
|
China | CN¥29.03 Billion |
|
NagaCorp Ltd
F:N9J
|
Germany | €367.58 Million |
|
Dongguan Eontec Co Ltd
SHE:300328
|
China | CN¥1.93 Billion |
|
Luenmei Quantum Co Ltd
SHG:600167
|
China | CN¥4.37 Billion |
|
Entra ASA
OL:ENTRA
|
Norway | Nkr40.52 Billion |
|
NCR Atleos Corporation
NYSE:NATL
|
USA | $5.46 Billion |
|
PARK24 SPONS. ADR/1
F:3WN
|
Germany | €256.18 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Syngene International Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Syngene International Limited.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syngene International Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syngene International Limited (2010–2025)
The table below shows the annual total liabilities of Syngene International Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs20.69 Billion ≈ $223.77 Million |
+9.26% |
| 2024-03-31 | Rs18.94 Billion ≈ $204.81 Million |
-14.42% |
| 2023-03-31 | Rs22.13 Billion ≈ $239.33 Million |
-2.35% |
| 2022-03-31 | Rs22.66 Billion ≈ $245.08 Million |
+9.91% |
| 2021-03-31 | Rs20.62 Billion ≈ $222.98 Million |
+3.76% |
| 2020-03-31 | Rs19.87 Billion ≈ $214.90 Million |
+14.52% |
| 2019-03-31 | Rs17.35 Billion ≈ $187.64 Million |
+18.15% |
| 2018-03-31 | Rs14.69 Billion ≈ $158.82 Million |
+7.93% |
| 2017-03-31 | Rs13.61 Billion ≈ $147.15 Million |
+1.80% |
| 2016-03-31 | Rs13.37 Billion ≈ $144.56 Million |
+131.82% |
| 2015-03-31 | Rs5.77 Billion ≈ $62.36 Million |
+8.47% |
| 2014-03-31 | Rs5.32 Billion ≈ $57.49 Million |
+158.56% |
| 2013-03-31 | Rs2.06 Billion ≈ $22.23 Million |
-29.05% |
| 2012-03-31 | Rs2.90 Billion ≈ $31.34 Million |
+2.26% |
| 2011-03-31 | Rs2.83 Billion ≈ $30.65 Million |
-11.02% |
| 2010-03-31 | Rs3.19 Billion ≈ $34.44 Million |
-- |
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more